Amgen (AMGN) EV to EBITDA (2009 - 2026)
Amgen (AMGN) posted EV to EBITDA of 51.73 for Q2 2026, down 22.46% on a QoQ basis from 66.71 in Q1 2026, and down 3.43% year-over-year from 53.57 in Q2 2025.
Analysis
Amgen (AMGN) EV to EBITDA (2009 - 2026) Analysis & Trends
Amgen has reported EV to EBITDA for 18 years, with the latest figure at 51.73 in Q2 2026.
- On a quarterly basis, EV to EBITDA fell 3.43% year-over-year to 51.73 in Q2 2026; TTM through Jun 2026 was 15.91, a 8.4% decrease from a year earlier, with the FY2025 full-year figure at 18.42, up 4.46% from the prior year.
- EV to EBITDA was 51.73 for Q2 2026 at Amgen, down from 66.71 in the prior quarter.
- The five-year high for EV to EBITDA was 144.1 in Q1 2024, with the low at 31.49 in Q2 2023.
- Average EV to EBITDA over 5 years is 68.97, with a median of 56.46 recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: EV to EBITDA slumped 64.22% in 2022, then surged 183.72% in 2024.
- Over 5 years, EV to EBITDA stood at 58.72 in 2022, then jumped by 91.96% to 112.72 in 2023, then plunged by 50.87% to 55.37 in 2024, then climbed by 11.03% to 61.48 in 2025, then fell by 15.86% to 51.73 in 2026.
- The last three EV to EBITDA figures came in at 51.73 (Q2 2026), 66.71 (Q1 2026), and 61.48 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.73 |
| Mar 31, 2026 | 66.71 |
| Dec 31, 2025 | 61.48 |
| Sep 30, 2025 | 56.42 |
| Jun 30, 2025 | 53.57 |
| Mar 31, 2025 | 134.73 |
| Dec 31, 2024 | 55.37 |
| Sep 30, 2024 | 80.20 |
| Jun 30, 2024 | 83.05 |
| Mar 31, 2024 | 144.10 |
| Dec 31, 2023 | 112.72 |
| Sep 30, 2023 | 53.97 |
| Jun 30, 2023 | 31.49 |
| Mar 31, 2023 | 50.79 |
| Dec 31, 2022 | 58.72 |
| Sep 30, 2022 | 40.89 |
| Jun 30, 2022 | 56.51 |
| Mar 31, 2022 | 49.05 |
| Dec 31, 2021 | 51.03 |
| Sep 30, 2021 | 45.09 |